Vitasora Health Limited (ASX:VHL)

Market Cap	59.86M
Revenue (ttm)	1.85M
Net Income (ttm)	-7.58M
Shares Out	1.58B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,111,245
Average Volume	1,059,405
Open	0.0420
Previous Close	0.0420
Day's Range	0.0360 - 0.0420
52-Week Range	0.0300 - 0.0440
Beta	-0.42
RSI	n/a
Earnings Date	May 27, 2025

About Vitasora Health

Vitasora Health Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. It also provides critical patient health tracking services to clinicians and healthcare teams. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company was inco...

• Industry: Other
• Founded: 1987
• Employees: 30
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VHL

Financial Performance

In 2024, Vitasora Health's revenue was 1.04 million, an increase of 56.85% compared to the previous year's 662,103. Losses were -7.13 million, 23.4% more than in 2023.